Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Metabolomics : Official Journal of the Metabolomic Society|June 21, 2023
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patientsAndrea Zapater-Moros, Leticia Díaz-Beltrán, Angelo Gámez-Pozo, et al.
BMC Cancer|June 30, 2010
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancerIker Sánchez-Navarro, Angelo Gámez-Pozo, Alvaro Pinto, et al.
BMC Cancer|December 25, 2008
Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studiesEva Barroso, Lara P Fernandez, Roger L Milne, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2026
Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo modelAngelo Gámez-Pozo, Luz Vega-Clemente, Lucía Trilla-Fuertes, et al.
International Journal of Molecular Sciences|February 27, 2026
NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative ReviewJesús Peña-López, Angelo Gámez-Pozo, Lucía Trilla-Fuertes, et al.
Oncotarget|March 19, 2016
Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxelMarta Mendiola, Virginia Martínez-Marin, Jesús Herranz, et al.
Pharmaceutics|November 27, 2021
<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer PatientsAlejandro Velasco-Ruiz, Rocio Nuñez-Torres, Guillermo Pita, et al.
BMC Cancer|April 16, 2020
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancerLucía Trilla-Fuertes, Angelo Gámez-Pozo, Elena López-Camacho, et al.
Proteomics|October 8, 2021
Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomicsSilvia García-Adrián, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, et al.
Scientific Reports|February 9, 2019
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognosesGuillermo Prado-Vázquez, Angelo Gámez-Pozo, Lucía Trilla-Fuertes, et al.
Pageof 13